Sunday, November 22, 2026
28.1 C
Bengaluru

The Anatomy of a Miscalculation: Why Maharashtra’s Homeopathic Prescription Policy Defies Global Medical Standards

In an attempt to bridge the urban-rural healthcare divide, the Maharashtra government passed a policy allowing homoeopathic practitioners—upon completing a one-year Certificate Course in Modern Pharmacology (CCMP)—to prescribe select modern allopathic medicines. While framed by state authorities as a pragmatic solution to a shortage of MBBS doctors in primary health centres, the policy flies in the face of established medical protocols regarding scope of practice, cross-prescription, and patient safety.

An analysis of treatment protocols in India, the United States, and Europe reveals a universal truth: prescriptive authority is inextricably tied to the depth and rigour of medical education, not the completion of a supplementary bridge program.

The Indian Jurisprudential and Legislative Context

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

USFDA Crackdown on Indian Pharma: Lessons for Indian Regulator

The US Food and Drug Administration has made unannounced...

The era of regulatory arbitrage in Indian nutraceuticals is officially over.

With the FSSAI suspending licenses across six nutraceutical manufacturers...

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Topics

USFDA Crackdown on Indian Pharma: Lessons for Indian Regulator

The US Food and Drug Administration has made unannounced...

The era of regulatory arbitrage in Indian nutraceuticals is officially over.

With the FSSAI suspending licenses across six nutraceutical manufacturers...

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...
spot_img

Related Articles

spot_imgspot_img